Pemetrexed monotherapy as salvage treatment in metastatic colorectal cancer patients who failed standard chemotherapy: A phase II single-arm prospective trial.

被引：0

作者：

Lim, Sung Won ^{[1
]}

Cho, Jangho ^{[1
]}

Lee, Jeeyun ^{[1
]}

Park, Se Hoon ^{[1
]}

Park, Joon Oh ^{[1
]}

Park, Young Suk ^{[1
]}

Lim, Ho Yeong ^{[1
]}

Kang, Won Ki ^{[1
]}

Kim, Seung Tae ^{[1
]}

机构：

[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期

关键词：

D O I：

10.1200/JCO.2018.36.4_suppl.840

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

840

引用

页数：1

共 50 条

[1] Pemetrexed Monotherapy as Salvage Treatment in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy: A Phase II Single-arm Prospective Trial
Lim, Sung Won
Lee, Sujin
Lee, Jeeyun
Park, Se Hoon
Park, Joon Oh
Park, Young Suk
Lim, Ho Yeong
Kang, Won Ki
Kim, Seung Tae
JOURNAL OF CANCER, 2018, 9 (16): : 2910 - 2915
[2] Pemetrexed and Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer Who Failed Gemcitabine-containing Chemotherapy: A Phase II Single-arm Prospective Study
Lim, Sung Hee
Hong, Jung Yong
Park, Joon Oh
Park, Young Suk
Kim, Seung Tae
ANTICANCER RESEARCH, 2023, 43 (09) : 4161 - 4167
[3] Pemetrexed/Erlotinib as a Salvage Treatment in Patients with High EGFR-Expressing Metastatic Colorectal Cancer Following Failure of Standard Chemotherapy: A Phase II Single-Arm Prospective Study
Kim, Seung Tae
Hong, Jung Yong
Lee, Jeeyun
Park, Joon Oh
Lim, Ho Young
Kang, Won Ki
Park, Young Suk
TARGETED ONCOLOGY, 2020, 15 (01) : 67 - 73
[4] Pemetrexed/Erlotinib as a Salvage Treatment in Patients with High EGFR-Expressing Metastatic Colorectal Cancer Following Failure of Standard Chemotherapy: A Phase II Single-Arm Prospective Study
Seung Tae Kim
Jung Yong Hong
Jeeyun Lee
Joon Oh Park
Ho Young Lim
Won Ki Kang
Young Suk Park
Targeted Oncology, 2020, 15 : 67 - 73
[5] Pemetrexed plus erlotinib as a salvage treatment in high EGFR-expressing metastatic colorectal cancer patients following failure of standard chemotherapy: A phase II single-arm prospective study
Byeon, Seonggyu
Kim, Seung Tae
Hong, Jung Yong
Lee, Jeeyun
Park, Joon Oh
Lim, Ho-Yeong
Kang, Won Ki
Park, Young Suk
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[6] Apatinib Monotherapy for Chemotherapy-Refractory Metastatic Colorectal Cancer: A Multi-centre, Single-Arm, Prospective Study
Wang, Fen
Yuan, Xia
Jia, Jun
Bi, Xiaoxia
Zhou, Zeqiang
Zhou, Qiming
Li, Xia
Luo, Changguo
Deng, Minghui
Yi, Liangjie
Li, Yong
Lu, Jianxin
Su, Wenzhi
Chen, Hanbin
Zhu, Yu
Wang, Shubin
SCIENTIFIC REPORTS, 2020, 10 (01)
[7] Apatinib Monotherapy for Chemotherapy-Refractory Metastatic Colorectal Cancer: A Multi-centre, Single-Arm, Prospective Study
Fen Wang
Xia Yuan
Jun Jia
Xiaoxia Bi
Zeqiang Zhou
Qiming Zhou
Xia Li
Changguo Luo
Minghui Deng
Liangjie Yi
Yong Li
Jianxin Lu
Wenzhi Su
Hanbin Chen
Yu Zhu
Shubin Wang
Scientific Reports, 10
[8] Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial
Liu, Rui
Ji, Zhi
Wang, Xia
Zhu, Lila
Xin, Jiaqi
Ma, Lijun
Zhang, Jiayu
Ge, Shaohua
Zhang, Le
Yang, Yuchong
Ning, Tao
Bai, Ming
Duan, Jingjing
Wang, Feixue
Sun, Yansha
Li, Hongli
Deng, Ting
Ba, Yi
Hao, Jihui
NATURE COMMUNICATIONS, 2025, 16 (01)
[9] A phase II study of pemetrexed and erlotinib for metastatic colorectal cancer refractory to standard chemotherapy
Beom, S-H.
Lee, K-W.
Cho, S-H.
Park, Y. S.
Kim, T. W.
Lee, K. H.
Jung, M.
Shin, S. J.
Ahn, J. B.
ANNALS OF ONCOLOGY, 2018, 29 : 190 - 190
[10] A prospective, single-arm, phase II trial evaluating the efficacy and safety of niraparib monotherapy maintenance treatment in patients with recurrent and metastatic (R/M) endometrial cancer (EC)
Zhu, Jianqing
Wang, Junjian
Shao, Feng
Cheng, Feng
Chen, Zhongbo
Sun, Lu
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A173 - A174

← 1 2 3 4 5 →